✦ LIBER ✦

Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis

✍ Scribed by C. Leonardi; A. Menter; T. Hamilton; I. Caro; B. Xing; A.B. Gottlieb

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Practical guidelines for the long-term t

✍ Craig L. Leonardi; Kim A. Papp; Jan D. Bos 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

P108 Clinical study of cyclosporin thera

✍ M. Ohtsuki; H. Nakagawa; K. Tamaki; T. Horikoshi; K. Jimbo; A. Ozawa; J. Sugai; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

Intermittent short courses of cyclospori

✍ Vincent C.Y. Ho; Christopher E.M. Griffiths; John Berth-Jones; Kim A. Papp; Fran 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 175 KB

The safety of etretinate as long-term th

✍ Robert S Stern; Elizabeth Fitzgerald; Charles N Ellis; Nicholas Lowe; Michael T 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 916 KB

The long-term tolerability and efficacy

✍ R Taurelle; M L’Hermite; W Haenggi; C Lauritzen; J.W Studd 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Long-term efficacy and safety of adalimu

✍ Kenneth Gordon; Kim Papp; Yves Poulin; Yihua Gu; Stephen Rozzo; Eric H. Sasso 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 347 KB